A novel Bcl-2/Bcl-XL inhibitor APG-1252-12A as a potential therapeutic strategy for gastric carcinoma

被引：0
|
作者：
Yan, Xianglei [1 ]
Yi, Hanjie [1 ]
Luo, Qiuyun [1 ]
Yuan, Luping [1 ]
Zhou, Suna [1 ]
Pan, Wentao [2 ]
Zhang, Lin [1 ]
Qiu, Miaozhen [1 ]
Yang, Dajun [1 ]
机构：
[1] Sun Yat Sen Univ, Ctr Canc, Guangzhou, Guangdong, Peoples R China
[2] Ascentage Pharma Inc, Suzhou, Peoples R China
来源：
CANCER RESEARCH | 2019年 / 79卷 / 13期
关键词：
D O I：
10.1158/1538-7445.AM2019-2054
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
2054
引用
收藏
页数：2
相关论文
共 50 条
  • [31] Evaluation of Mcl-1, Bcl-xL, Bcl-2 Expression as Potential Therapeutic Targets for Colorectal Adenocarcinoma
    Dermawan, Josephine
    Demelash, Abeba
    Gastman, Brian
    Mayell, Cameron
    Pfannenstiel, Lukas
    Kalady, Matthew
    DeVecchio, Jennifer
    Patil, Deepa T.
    MODERN PATHOLOGY, 2018, 31 : 258 - 258
  • [32] Evaluation of Mcl-1, Bcl-xL, Bcl-2 Expression as Potential Therapeutic Targets for Colorectal Adenocarcinoma
    Dermawan, Josephine
    Demelash, Abeba
    Gastman, Brian
    Mayell, Cameron
    Pfannenstiel, Lukas
    Kalady, Matthew
    DeVecchio, Jennifer
    Patil, Deepa T.
    LABORATORY INVESTIGATION, 2018, 98 : 258 - 258
  • [33] Predicting drug sensitivity to a novel BCL-2 and BCL-xL dual inhibitor in solid tumor PDX trials
    Deng, Jing
    Huang, Xiaojing
    Zhai, Guoqin
    Mao, Tingting
    Yin, Yan
    Fang, Douglas D.
    Yang, Dajun
    Zhai, Yifan
    CANCER RESEARCH, 2019, 79 (13)
  • [34] Cotargeting BCL-2 and BCL-XL for maximal efficacy in ALL
    Daver, Naval
    Konopleva, Marina
    BLOOD, 2016, 128 (10) : 1316 - 1317
  • [35] Unknotting the roles of Bcl-2 and Bcl-xL in cell death
    Kim, R
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2005, 333 (02) : 336 - 343
  • [36] Antiapoptotic bcl-2 and bcl-xL in advanced malignant melanoma
    U. Leiter
    R. M. Schmid
    P. Kaskel
    R. U. Peter
    G. Krähn
    Archives of Dermatological Research, 2000, 292 : 225 - 232
  • [37] Antiapoptotic bcl-2 and bcl-xL in advanced malignant melanoma
    Leiter, U
    Schmid, RM
    Kaskel, P
    Peter, RU
    Krähn, G
    ARCHIVES OF DERMATOLOGICAL RESEARCH, 2000, 292 (05) : 225 - 232
  • [38] EXPRESSION OF BCL-2 AND BCL-XL IN BREAST-CANCER
    CARROLL, AG
    LIPPMAN, ME
    MOLECULAR BIOLOGY OF THE CELL, 1995, 6 : 1439 - 1439
  • [39] APG-1252 combined with Cabozantinib inhibits hepatocellular carcinoma by suppressing MEK/ERK and CREB/Bcl-xl pathways
    Di, Tian
    Luo, Qiu-yun
    Song, Jiang-tao
    Yan, Xiang-lei
    Zhang, Lin
    Pan, Wen-tao
    Guo, Yu
    Lu, Fei-teng
    Sun, Yu-ting
    Xia, Zeng-fei
    Yang, Li-qiong
    Qiu, Miao-zhen
    Yang, Da-jun
    Sun, Jian
    INTERNATIONAL IMMUNOPHARMACOLOGY, 2024, 139
  • [40] Overexpression of bcl-2 or bcl-XL fails to inhibit apoptosis mediated by a novel retinoid
    Fontana, JA
    Sun, RJ
    Rishi, AK
    Dawson, MI
    Ordonez, JV
    Zhang, YX
    Tschang, SH
    Bhalla, K
    Han, ZY
    Wyche, J
    Poirier, G
    Sheikh, MS
    Shroot, B
    Reichert, U
    ONCOLOGY RESEARCH, 1998, 10 (06) : 313 - 324
12345